Search Results

Risk for Recurrent Venous Thromboembolism in Patients With Subsegmental Pulmonary Embolism Managed Without Anticoagulation.

• Authors : Carrier, Marc¹ (AUTHOR); Le Gal, Grégoire² (AUTHOR)

Subjects: *THROMBOEMBOLISM; *PULMONARY embolism; *ANTICOAGULANTS

• Source: Annals of Internal Medicine. Apr2022, Vol. 175 Issue 4, pW43-W44. 2p.

Record details

In adults with VTE who received anticoagulants for ≥3 mo, VTE-PREDICT predicted recurrence and bleeding at up to 5 y.

• Authors : White, Richard H.¹ (AUTHOR)

Subjects: *DISEASE risk factors; *THROMBOEMBOLISM; *ANTICOAGULANTS

• Source: Annals of Internal Medicine. May2023, Vol. 176 Issue 5, pJC59-JC59. 1p.

Record details

Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism : A Systematic Review and Meta-analysis.

• Authors : Khan, Faizan¹ (AUTHOR); Tritschler, Tobias² (AUTHOR); Kimpton, Miriam³ (AUTHOR)

Subjects: *THROMBOEMBOLISM; *ANTICOAGULANTS; *HEMORRHAGE

• Source: Annals of Internal Medicine. 10/19/2021, Vol. 174 Issue 10, p1420-1429. 10p. 1 Diagram, 10 Charts, 1 Graph.

Record details

Risk for Recurrent Venous Thromboembolism and Bleeding With Apixaban Compared With Rivaroxaban: An Analysis of Real-World Data.

• Authors : Dawwas, Ghadeer K.¹ (AUTHOR); Leonard, Charles E.¹ (AUTHOR); Lewis, James D.¹ (AUTHOR)

Subjects: *THROMBOEMBOLISM; *ANTICOAGULANTS; *APIXABANUNITED States

• Source: Annals of Internal Medicine. 1/18/2022, Vol. 175 Issue 1, p20-28. 9p. 13 Charts, 2 Graphs.

Record details

Annals Consult Guys - Standardizing Venous Thromboembolism Prophylaxis in the Setting of Orthopedic Surgery.

• Authors : Weitz, Howard H.¹ (AUTHOR); Merli, Geno J.¹ (AUTHOR)

Subjects: *THROMBOEMBOLISM; *PREVENTIVE medicine; *HISTORICAL source material

• Source: Annals of Internal Medicine. Sep2022, Vol. 175 Issue 9, pCG1-CG1. 1p.

Record details

Risk for Recurrent Venous Thromboembolism in Patients With Subsegmental Pulmonary Embolism Managed Without Anticoagulation.

• Authors : Westafer, Lauren M.¹ (AUTHOR); Vinson, David R.² (AUTHOR)

Subjects: *THROMBOEMBOLISM; *PULMONARY embolism; *ANTICOAGULANTS

• Source: Annals of Internal Medicine. Apr2022, Vol. 175 Issue 4, pW43-W43. 1p.

Record details

Post-TKA abelacimab reduced VTE at 8 to 12 d compared with enoxaparin.

• Authors : Dunn, Andrew S.¹ (AUTHOR)

Subjects: *ENOXAPARIN; *THROMBOEMBOLISM; *BIBLIOGRAPHICAL citations

• Source: Annals of Internal Medicine. 12/21/2021, Vol. 174 Issue 12, pJC136-JC136. 1p.

Record details

Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism.

• Authors : Brouillard, Philippe¹ (AUTHOR); LeLorier, Jacques¹ (AUTHOR)

Subjects: *THROMBOEMBOLISM; *HEMORRHAGE; *ANTICOAGULANTS

• Source: Annals of Internal Medicine. Feb2022, Vol. 175 Issue 2, pW14-W14. 1p. 1 Chart.

Record details

Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism.

• Authors : Khan, Faizan¹ (AUTHOR); Tritschler, Tobias² (AUTHOR); Le Gal, Gregoire³ (AUTHOR)

Subjects: *THROMBOEMBOLISM; *HEMORRHAGE; *ANTICOAGULANTS

• Source: Annals of Internal Medicine. Feb2022, Vol. 175 Issue 2, pW14-W14. 1p. 1 Chart.

Record details

Summary for Patients: Bleeding Risk During Extended Anticoagulant Therapy for Venous Thromboembolism.

Subjects: *THROMBOEMBOLISM; *ANTICOAGULANTS; *HEMORRHAGE

• Source: Annals of Internal Medicine. 10/19/2021, Vol. 174 Issue 10, pI-30-I-30. 1p.

Record details